![Stephen Mahoney](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Stephen Mahoney
Director Ejecutivo en VIRIDIAN THERAPEUTICS, INC. .
Fortuna: 23 317 $ al 31/05/2024
Cargos activos de Stephen Mahoney
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
VIRIDIAN THERAPEUTICS, INC. | Director/Miembro de la Junta | 30/10/2023 | - |
Director Ejecutivo | 30/10/2023 | - | |
Presidente | 30/10/2023 | - | |
Vesselon, Inc.
![]() Vesselon, Inc. Medical SpecialtiesHealth Technology Vesselon, Inc. develops a portable ultrasound medical device for treating neurodegenerative diseases and brain & ischemic strokes. It commercializes a drug delivery platform that combines ultrasound and microbubbles to deliver the drugs across tissue barriers directly into a target without the need to modify the drug through a process, microbubble assisted sono-therapy. The company was founded by Clayton T. Larsen and Rhodemann Li in 2012 and is headquartered in Norwalk, CT. | Director/Miembro de la Junta | - | - |
Historial de carrera de Stephen Mahoney
Antiguos cargos conocidos de Stephen Mahoney.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
DIANTHUS THERAPEUTICS, INC. | Director de Operaciones | 01/11/2020 | 01/09/2023 |
Director Financiero/CFO | 01/11/2020 | 01/09/2023 | |
KINIKSA PHARMACEUTICALS, LTD. | Director de Operaciones | 01/07/2015 | 15/11/2019 |
Fundador | 01/07/2015 | 15/11/2019 | |
Presidente | 01/06/2017 | 15/11/2019 | |
SYNAGEVA BIOPHARMA CORP | Corporate Officer/Principal | 05/11/2013 | 01/01/2015 |
Genzyme Corp.
![]() Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - | - |
MAGENTA THERAPEUTICS | Comptroller/Controller/Auditor | 02/11/2020 | 07/02/2023 |
Director de Operaciones | 02/11/2020 | - | |
Director Financiero/CFO | 02/11/2020 | - | |
Presidente | 07/02/2023 | - | |
Treasurer | 02/11/2020 | 07/02/2023 | |
Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC
![]() Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC Miscellaneous Commercial ServicesCommercial Services Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC provides legal services. The firm offers services to the communications, education, environmental, health, immigration, public finance, real estate and tax industries. The company was founded in 1933 and is headquartered in Boston, MA. | Corporate Officer/Principal | - | - |
Formación de Stephen Mahoney.
The Colorado College | Undergraduate Degree |
Boston College Law School | Graduate Degree |
Wallace E Carroll School of Management | Masters Business Admin |
Estadísticas
Internacional
Estados Unidos | 12 |
Operativa
Corporate Officer/Principal | 3 |
Chief Operating Officer | 3 |
President | 3 |
Sectorial
Health Technology | 8 |
Consumer Services | 4 |
Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 3 |
---|---|
KINIKSA PHARMACEUTICALS, LTD. | Health Technology |
VIRIDIAN THERAPEUTICS, INC. | Health Technology |
DIANTHUS THERAPEUTICS, INC. | Health Technology |
Empresas privadas | 5 |
---|---|
Synageva BioPharma Corp.
![]() Synageva BioPharma Corp. BiotechnologyHealth Technology Synageva BioPharma Corp. is a biopharmaceutical company which focuses on the discovery, development, and commercialization of therapeutic products for patients with life-threatening rare diseases and high unmet medical need. The company is currently evaluating sebelipase alfa in global clinical trials for LAL Deficiency, a lysosomal storage disease associated with liver damage and accelerated atherosclerosis in children and adults, and in infants, premature death often before six months of age. Synageva BioPharma was founded in 1993 and is headquartered in Lexington, MA. | Health Technology |
Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC
![]() Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC Miscellaneous Commercial ServicesCommercial Services Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC provides legal services. The firm offers services to the communications, education, environmental, health, immigration, public finance, real estate and tax industries. The company was founded in 1933 and is headquartered in Boston, MA. | Commercial Services |
Magenta Therapeutics, Inc.
![]() Magenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Magenta Therapeutics, Inc. is a biotechnology company, which focuses on improving stem cell transplantation. Its platform includes MGTA-117, MGTA-145, and CD45-ADC. The company was founded by David T. Scadden, Derrick J. Rossi, Alan Tyndall, Luigi Naldini, Robert Negrin, John F. Dipersio, and Jason Gardner on June 17, 2015 and is headquartered in Cambridge, MA. | Health Technology |
Vesselon, Inc.
![]() Vesselon, Inc. Medical SpecialtiesHealth Technology Vesselon, Inc. develops a portable ultrasound medical device for treating neurodegenerative diseases and brain & ischemic strokes. It commercializes a drug delivery platform that combines ultrasound and microbubbles to deliver the drugs across tissue barriers directly into a target without the need to modify the drug through a process, microbubble assisted sono-therapy. The company was founded by Clayton T. Larsen and Rhodemann Li in 2012 and is headquartered in Norwalk, CT. | Health Technology |
Genzyme Corp.
![]() Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Stephen Mahoney
- Experiencia